ADHD in adults

Attention Deficit Hyperactivity Disorder: Concepts, Controversies, New Directions

Volumn , Issue , 2007, Pages 273-290

  Wilens, Timothy E ^a   Prince, Jefferson ^a   Biederman, Joseph ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 78651413629     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.3109/9781420017144-28     Document Type: Chapter

References (86)

1. Faraone SV, Sergeant J, Gillberg C, Biederman J. The worldwide prevalence of ADHD: Is it an American condition? World Psychiatry 2003; 2:104-13.
2. Kessler R. The prevalence and correlates of adult ADHD in the United States: Results from the National comorbidity Survey Replication. Am J Psychiatry 2006; 163:716-23.
3. Murphy K, Barkley RA. Prevalence of DSM-IV symptoms of ADHD in adult licensed drivers: Implications for clinical diagnosis. J Atten Disord 1996; 1: 147-61.
4. Weiss G, Hechtman L, Milroy T, Perlman T. Psychiatric status of hyperactives as adults: A controlled prospective 15 year followup of 63 hyperactive children. J Am Acad Child Adolesc Psychiatry 1985; 24:211-20.
5. Hill JC, Schoener EP. Age-dependent decline of attention deficit hyperactivity disorder. Am J Psychiatry 1996; 153:1143-6.
6. Spencer T, Biederman J, Wilens T, Faraone S. Adults with attention-deficit/ hyperactivity disorder: A controversial diagnosis. J Clin Psychiatry 1998; 59 (Suppl. l):59-68.
7. Wilens T, Faraone SV, Biederman J. Attention-deficit/hyperactivity disorder in adults. J Am Med Assoc 2004; 292:619-23.
8. Achenbach TM, Howell C, McConaughy S, Stanger C. Six-year predictors of problems in a national sample: IV. Young adult signs of disturbance. J Am Acad Child Adolesc Psychiatry 1998; 37:718-27.
9. Biederman J, Faraone S, Mick E. Age dependent decline of ADHD symptoms revisited: Impact of remission definition and symptom subtype. Am J Psychiatry 2000; 157:816-7.
10. Hart EL, Lahey BB, Loeber R, Applegate B, Frick PJ. Developmental change in attention-deficit hyperactivity disorder in boys: A four-year longitudinal study. J Abnorm Child Psychol 1995; 23:729-49.
11. Millstein RB, Wilens TE, Biederman J, Spencer TJ. Presenting ADHD symptoms and subtypes in clinically referred adults with ADHD. J Atten Disord 1997; 2:159-66.
12. Barkley RA. Behavioral inhibition, sustained attention, and executive functions: Constructing a unifying theory of ADHD. Psychol Bull 1997; 121:65-94.
13. Wender P. The hyperactive Child, Adolescent, and Adult: Attention Deficit Disorder Through the Lifespan. New York: Oxford University Press, 1987.
14. Wilens T, Dodson W. A clinical perspective of ADHD into adulthood. J Clin Psychiatry, 2004; 65:1301-13.
15. Heiligenstein E, Conyers LM, Berns AR, Miller MA, Smith MA. Preliminary normative data on DSM-IV attention deficit hyperactivity disorder in college students [published erratum appears in J Am Coll Health 1998 Mar; 46:213]. J Am Coll Health 1998; 46:185-8.
16. Biederman J, Faraone SV, Spencer T, et al. Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. Am J Psychiatry 1993; 150:1792-8.
17. Barkley RA, Murphy KR, Dupaul GI, Bush T. Driving in young adults with attention deficit hyperactivity disorder: Knowledge, performance, adverse outcomes, and the role of executive functioning. J Int Neuropsychol Soc 2002; 8:655-72.
18. Stein MA. Unravelling sleep problems in treated and untreated children with ADHD. J Child Adolesc Psychopharmacol 1999; 9:157-68.
19. Murphy P, Schachar R. Use of self-ratings in the assessment of symptoms of attention deficit hyperactivity disorder in adults. Am J Psychiatry 2000; 157: 1156-9.
20. Mannuzza S, Klein RG, Klein DF, Bessler A, Shrout P. Accuracy of adult recall of childhood attention deficit hyperactivity disorder. Am J Psychiatry 2002; 159:1882-8.
21. Adler L, Cohen J. Diagnosis and evaluation of adults with ADHD. In Spencer T, ed. Psychiatric Clinics of North America, Vol. 27. Philadelphia, PA: Saunders Press, 2004:187-202.
22. Alpert J, Maddocks A, Nierenberg A, et al. Attention deficit hyperactivity disorder in childhood among adults with major depression. Psychiatry Res 1996; 62:213-9.
23. Fones CS, Pollack MH, Susswein L, Otto M. History of childhood attention deficit hyperactivity disorder (ADHD) features among adults with panic disorder. J Affect Disord 2000; 58:99-106.
24. Levin FR, Evans S, Kleber HD. Prevalence of adult attention-deficit/ hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998; 52:15-25.
25. Nierenberg A, Yan LJ, McMurrich SL, et al. ADHD in adults with bipolar disorder in the systematic treatment enhancement program for bipolar disorder. Paper Presented at the 156th Annual Meeting of the American Psychiatric Association, San Francisco, CA, 2002, May 17-22, 2003.
26. Schubiner H, Tzelepis A, Milberger S, et al. Prevalence of attention-deficit/ hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000; 61:244-51.
27. Wilens T. Attention-deficit/hyperactivity disorder and the substance use disorders: The nature of the relationship, subtypes at risk and treatment issues. In: Spencer T, ed. Psychiatric Clinics of North America, Vol. 27. Philadelphia, PA: Saunders Press, 2004:283-302.
28. Biederman J, Wilens TE, Mick E, Milberger S, Spencer TJ, Faraone SV. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): Effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995; 152:1652-8.
29. Wilens T, Biederman J, Mick E. Does ADHD affect the course of substance abuse? Findings from a sample of adults with and without ADHD. Am J Addict 1998; 7:156-63.
30. Wilens TE, Biederman J, Mick E, Faraone SV, Spencer T. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance use disorders. J Nerv Ment Dis 1997; 185:475-82.
31. Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993; 34:75-82.
32. Levin FR, Evans SM. Diagnostic and treatment issues in comorbid substance abuse and adult attention-deficit hyperactivity disorder. Psychiatric Ann 2001; 31:303-12.
33. Faraone SV. Genetics of adult attention deficit hyperactivity disorder. In: Spencer T, ed. Psychiatric Clinics of North America, Vol. 27. Philadelphia, PA: Saunders Press, 2004:303-21.
34. Faraone SV, Biederman J. Pathophysiology of attention-deficit/hyperactivity disorder. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology: The Fifth Generation of Progress. Philadelphia, PA: Lippincott Williams & Wilkins, 2002:577-96.
35. Hudziak J, Heath A, Madden P, et al. Latent class and factor analysis of DMS-IV ADHD: A twin study of female adolescents. J Am Acad Child Adolesc Psychiatry 1998; 37:848-57.
36. Biederman J, Faraone SV, Mick E, et al. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: A pilot study. Am J Psychiatry 1995; 152:431-5.
37. Wilens T, Hahesy A, Biederman J, et al. Influence of parental SUD and ADHD on ADHD in their offspring: Preliminary Results from a Pilot Controlled Family Study. Am J Addict, 2005; 14:179-87.
38. Cook EH, Stein MA, Krasowski MD, et al. Association of attention deficit disorder and the dopamine transporter gene. Am J Hum Genet 1995; 56:993-8.
39. Faraone SV. Report from the third international meeting of the attention-deficit hyperactivity disorder molecular genetics network. Am J Med Genet 2002; 114:272-6.
40. LaHoste GJ, Swanson JM, Wigal SB, et al. Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Mol Psychiatry 1996; 1:121-4.
41. Lanau F, Zenner M, Civelli O, Hartman D. Epinephrine and norepinephrine act as potent agonists at the recombinant human dopamine D4 receptor. J Neurochem 1997; 68:804-12.
42. Epstein JN, Conners CK, Erhardt D, March JS, Swanson JM. Asymmetrical hemispheric control of visual-spatial attention in adults with attention deficit hyperactivity disorder. Neuropsychology 1997; 11:467-73.
43. Hervey AS, Epstein J, Curry JF. The neuropsychology of adults with attention deficit hyperactivity disorder: A meta-analytic review. Neuropsychology, 2004; 18:485-503.
44. Johnson DE, Epstein JN, Waid LR, Latham PK, Voronin KE, Anton RF. Neuropsychological performance deficits in adults with attention deficit/ hyperactivity disorder. Arch Clin Neuropsychol 2001; 16:587-604.
45. Seidman L, Doyle A, Fried R, Valera E, Crum K, Matthews L. Neuropsychological functioning in adults with attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, Vol 27. 2004:261-82.
46. Seidman LJ, Valera E, Bush G. Brain function and structure in adults with attention-deficit/hyperactivity disorder. In: Spencer T, ed. Psychiatric Clinics of North America, Vol 27. Philadelphia, PA: Saunders Press, 2004: 323-47.
47. Schweitzer JB, Faber TL, Grafton ST, Tune L, Hoffman JM, Kilts CD. Alterations in the functional anatomy of working memory in adult ADHD. Am J Psychiatry 2000; 157:278-80.
48. Zametkin AJ, Nordahl TE, Gross M, et al. Cerebral glucose metabolism in adults with hyperactivity of childhood onset. N Engl J Med 1990; 323: 1361-6.
49. Bush G, Frazier JA, Rauch SL, et al. Anterior cingulate cortex dysfunction in attention-deficit/hyperactivity disorder revealed by fMRI and the Counting Stroop. Biol Psychiatry 1999; 45:1542-52.
50. Castellanos FX, Giedd JN, Berquin PC, et al. Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001; 58:289-95.
51. Castellanos FX, Lee PP, Sharp W, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/ hyperactivity disorder. JAMA 2002; 288:1740-48.
52. Dougherty D, Bonab A, Spencer T, Rauch S, Madras, B, Fischman A. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999; 354:2132-3.
53. Krause K, Dresel SH, Krause J, Kung HF, Tatsch K. Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: Effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 2000; 285:107-10.
54. Volkow N, Wang G, Fowler J, et al. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate. Am J Psychiatry 1998; 155:1325-31.
55. Ratey JJ, Greenberg MS, Bemporad JR, Lindem KJ. Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy. J Child Adolesc Psychopharmacol 1992; 2:267-75.
56. McDermott SP, Wilens TE. Cognitive therapy for adults with ADHD. In: Brown T, ed. Subtypes of Attention Deficit Disorders in Children, Adolescents, and Adults. Washington, D.C.: American Psychiatric Press, 2000:569-606.
57. Safren SA, Otto M, Sprich S, Winett C, Wilens T, Biederman J. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms. Behav Res Ther, 2005; 43:831-42.
58. Wilens T, McDermott S, Biederman J, Abrantes A, Hahesy A, Spencer T. Cognitive therapy in the treatment of adults with ADHD: A systematic chart review of 26 cases. J Cogn Psychother: Int Q 1999; 13:215-26.
59. Wilens T. Drug therapy for adults with attention-deficit hyperactivity disorder. Drugs 2003; 63:2395-411.
60. Wilens T, Spencer T. Pharmacology of amphetamines. In: Tarter R, Ammerman R, Ott P, eds. Handbook of Substance Abuse: Neurobehavioral Pharmacology. New York: Plenum Press, 1998:501-13.
61. Solanto, M. V. Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: A review and integration. Behav Brain Res 1998; 94:127-52.
62. Spencer T, Biederman J, Wilens T, et al. Efficacy of a mixed amphetamine salts compound in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2001; 58:775-82.
63. Spencer T, Wilens TE, Biederman J, Faraone SV, Ablon S, Lapey K. A double blind, crossover comparison of methylphenidate and placebo in adults with childhood onset attention deficit hyperactivity disorder. Arch Gen Psychiatry 1995; 52:434-43.
64. Wender PH, Reimherr FW, Wood D, Ward M. A controlled study of methylphenidate in the treatment of attention deficit disorder, residual type, in adults. Am J Psychiatry 1985; 142:547-52.
65. Michelson D, Adler L, Spencer T, et al. Atomoxetine in adults with ADHD: Two randomized, placebo-controlled studies. Biol Psychiatry 2003; 53:112-20.
66. Wilens T, Biederman J, Prince J, et al. Six-week, double blind, placebocontrolled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 1996; 153:1147-53.
67. Wilens T, Prince J, Biederman J, et al. An open study of sustained-release bupropion in adults with ADHD and substance use disorders. Paper Presented at the AACAP, Honolulu, HI, October 2001.
68. Chandler MC. Long-term safety and efficacy of Adderall extended release in children with ADHD. Paper Presented at the Annual Meeting of the American Psychiatric Association, Philadelphia, PA, 2002.
69. Spencer TJ, Biederman J. Efficacy in a 6-month trial of methylphenidate in adults with ADHD. Paper Presented at the Scientific Proceedings of the 49th Annual Meeting: American Academy of Child and Adolescent Psychiatry, San Francisco, CA, October 22-27, 2002.
70. Wilens T, Hammerness P, Biederman J, et al. Blood pressure changes associated with medication treatment of adults with attention-deficit/hyper-activity disorder. J Clin Psychiatry 2005; 66:253-9.
71. Drug Enforcement Administration. Methylphenidate Review Document. Washington, D.C.: Office of Diversion Control, Drug and Chemical Evaluation Section, 1995.
72. Babcock Q, Byrne T. Student perceptions of methylphenidate abuse at a public liberal arts college. J Am Coll Health 2000; 49:143-5.
73. Greenhill LL, Pliszka S, Dulcan MK, et al. Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry 2002; 41(Suppl. 2):26S-49S.
74. Ratey J, Greenberg M, Lindem K. Combination of treatments for attention deficit disorders in adults. J Nerv Ment Dis 1991; 176:699-701.
75. Markowitz JS, Morrison SD, DeVane CL. Drug interactions with psychostimulants. Int Clin Psychopharmacol 1999; 14:1-18.
76. Bymaster FP, Katner JS, Nelson DL, et al. Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology 2002; 27:699-711.
77. Heil SH, Holmes HW, Bickel WK, et al. Comparison of the subjective, physiological, and psychomotor effects of atomoxetine and methylphenidate in light drug users. Drug Alcohol Depend 2002; 67:149-56.
78. Wilens T, Haight BR, Horrigan JP, et al. Bupropion XL in adults with ADHD: A randomized, placebo-controlled study. Biol Psychiatry 2005; 57:793-801.
79. Wilens TE, Spencer TJ, Biederman J, et al. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 2001; 158:282-8.
80. Spencer T, Biederman J, Wilens T, Harding M, O’Donnell D, Griffin S. Pharmacotherapy of attention deficit disorder across the life cycle. J Am Acad Child Adolesc Psychiatry, 1996; 35:409-32.
81. Wilens T, Prince J, Spencer T, et al. An open trial of bupropion for the treatment of adults with attention deficit hyperactivity disorder and bipolar disorder. Biol Psychiatry 2003; 54:9-16.
82. Taylor FB. Comparing modafinil to dextroamphetamine in the treatment of adult ADHD. Paper Presented at the 153rd Annual Meeting of the American Psychiatric Association, Chicago, May 12-18, 2000.
83. Cox DJ, Merkel RL, Kovatchev B, Seward R. Effect of stimulant medication on driving performance of young adults with attention-deficit hyperactivity disorder: A preliminary double-blind placebo controlled trial. J Nerv Ment Dis 2000; 188:230-4.
84. Wilens T, Faraone S, Biederman J, Gunawardene S. Does stimulant therapy of ADHD beget later substance abuse: A meta-analytic review of the literature. Pediatrics 2003; 11:179-85.
85. Biederman J, Spencer T, Chrisman AK, Wilens T, Tulloch SJ, Weisler RH. Long-term safety and efficacy of mixed amphetamine salts extended-release for adult ADHD. Paper presented at the American Psychiatry Association 2004. Annual Meeting 2004; New York, NY.
86. Posner ML, Petersen SE. The attention system of the human brain. Annual Review of Neuroscience 1990; 13:25-42.